📈 What’s up investors! 📉
Welcome back to another one of
💡“Mike’s Ideas”.💡
I post as I find signals… these signals are based on the personal rules I have built and follow in order to make up what I call the “SST Strategy”. Follow for more ideas in the future!!
I have 4 levels marked and colour coded on the Chart.
These levels are:
🔴 Red = Stop Loss
🟢 Green =...
MRK broke below its trendline with both a MACD and RSI Divergence. Volume profile doesn't look supportive at these prices. Healthcare names have been a safe hiding place through the recent sell off
Nasty bearish engulfing candle larger than the previous 2 days. Had completed a 9count on 11/30, chopping around since, losing 108.6 volume shelf sends it down
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive...
The stock just broke through a perfect buy point and triggered a buy-signal. The stop loss level and profit target are shown in the graphic.
All stocks on our watchlists meet the hard selection criteria according to Mark Minervini's Trend-Template and William o' Neil's CAN SLIM methodology AND
are in the process of developing a Perfect Buy Point and a low-risk...
The PEAD projected a Bullish outlook for $MRK after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 75%.
Divergent on the downside across multiple timeframes. Betting on a triangle B formation, now due for a C Wave to the upside. No confirmation yet. Speculating that this might be a very short term event.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in...
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668. The company does business as Merck Sharp & Dohme outside the United States and Canada.
Merck was able to break the support lines. For now, it completed its pullback to support...
Merck and Company
Short Term
We look to Sell at 93.34 (stop at 96.33)
We look to sell rallies. Price action looks to be forming a top. Although the bulls are in control, the stalling positive momentum indicates a turnaround is possible. There is scope for mild buying at the open but gains should be limited.
Our profit targets will be 86.55 and 83.96...
One more huge pharma firm that is biting the dust. A giant flat with a C wave confirmed. No way but down on this one.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Confirmation level, where relevant, is a pink dotted,...
Earnings 7-28 before market opens.
ATH 96.69.
Horizontal trading channels that is neutral until a trendline is broken with a trend in that direction.
Targets above rectangle are targets to the upside if this were to break that way and vice versa.
If this were to break to the downside this would be a Rectangle Top.
No recommendation/Be safe (o:
It follows the pattern, but now the base is shifted. I expect it will stay at current level or rise a bit, before dropping after earnings towards the Dividend. If i had any money leftover, i would short it soon after earnings. Unfortunately my put options expired worthless. But that was my fault for buying at the wrong time.
